Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (141-150 of 441) with videos related to

Pageof 45
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 31, 2007
Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapyJean-David Zeitoun, Vincent Mallet, Marie-Laure Chaix, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfectionVincent Mallet, Michaël Schwarzinger, Anaïs Vallet-Pichard, et al.
Presse Medicale (Paris, France : 1983)|November 27, 2019
[FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients]Vincent Mallet, Lucia Parlati, Anaïs Vallet-Pichard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS studyZobair M Younossi, Maria Stepanova, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)|September 24, 2004
Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriersMaryline Mancini-Bourgine, Hélène Fontaine, Daniel Scott-Algara, et al.
Journal of Hepatology|October 8, 2018
Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective studyLucia Parlati, Anais Vallet-Pichard, Rui Batista, et al.
Journal of Hepatology|March 4, 2008
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02Patrice Cacoub, Fabrice Carrat, Pierre Bédossa, et al.
AIDS (London, England)|January 2, 2007
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patientsVincent Mallet, Pierre Blanchard, Virginie Verkarre, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 16, 2008
Influence of liver biopsy on abstinence in alcohol-dependent patientsJean-Baptiste Trabut, Arnaud Plat, Véronique Thepot, et al.
Journal of Hepatology|January 8, 2004
Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infectionPascal Lebray, Anaïs Vallet-Pichard, Marie-Louise Michel, et al.
Pageof 45

Showing results (141-150 of 441) with videos related to

Sort By:
Pageof 45
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 31, 2007
Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapyJean-David Zeitoun, Vincent Mallet, Marie-Laure Chaix, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfectionVincent Mallet, Michaël Schwarzinger, Anaïs Vallet-Pichard, et al.
Presse Medicale (Paris, France : 1983)|November 27, 2019
[FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients]Vincent Mallet, Lucia Parlati, Anaïs Vallet-Pichard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS studyZobair M Younossi, Maria Stepanova, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)|September 24, 2004
Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriersMaryline Mancini-Bourgine, Hélène Fontaine, Daniel Scott-Algara, et al.
Journal of Hepatology|October 8, 2018
Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective studyLucia Parlati, Anais Vallet-Pichard, Rui Batista, et al.
Journal of Hepatology|March 4, 2008
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02Patrice Cacoub, Fabrice Carrat, Pierre Bédossa, et al.
AIDS (London, England)|January 2, 2007
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patientsVincent Mallet, Pierre Blanchard, Virginie Verkarre, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 16, 2008
Influence of liver biopsy on abstinence in alcohol-dependent patientsJean-Baptiste Trabut, Arnaud Plat, Véronique Thepot, et al.
Journal of Hepatology|January 8, 2004
Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infectionPascal Lebray, Anaïs Vallet-Pichard, Marie-Louise Michel, et al.
Pageof 45